The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...

A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.

Drug makers have responded by setting list prices of about $1,000 per month per patient. People with obesity have wrestled with people with diabetes over access to the drugs. Workers have sued ...

Kailera Therapeutics has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China ...

The report shows a rise in medication use, obesity, and smoking, a decline in cancer screenings, concerns over excessive ...

Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes ...

The drug cost $219 for a month's supply, a fraction of the list price of $968 for a ... Finding fake or diverted Ozempic and other obesity drugs is common at the sprawling international mail ...